Inspections, Compliance, Enforcement, and Criminal Investigations
Walgreen Co. - Close Out Letter 3/21/11
| Public Health Service Food and Drug Administration |
Chicago District |
March 21, 2011
Mr. Gregory D. Wasson
President and CEO
Walgreen Company
200 Wilmot Road
Deerfield, IL 60015-4620
Dear Mr. Wasson:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to Warning Letter CHI-10-10 dated September 27, 2010. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory
action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Scott J MacIntire
District Director
Chicago District Office





Department of Health and Human Services

